ADME Toxicology Testing Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027Price: 3200/- USD | Published Date: September 2, 2020 |
The global ADME toxicology testing market is expected to grow at the CAGR of 10.2% during 2020-2027. The global ADME toxicology testing market is segmented on the basis of product type, technology type, and geography. The report on the global ADME toxicology testing market forecast 2017-2025 (by product type, technology, and geography) provides a detailed overview and predictive analysis of the market.
ADME toxicology is a novel concept that is being used in the market for drug discovery, development, and testing in pharmaceutical and biotechnology companies. ADME stands for absorption, distribution, metabolism, and elimination process which takes place when a drug is consumed by the human body. Thus the ADME process helps in understanding the drug performance on human tissue. The key drivers of the market include rapid adoption of in silico and in vitro toxicology testing, and cell-based assay systems in drug development and discovery and ADME analysis
ADME abbreviation stands for absorption distribution, metabolism, and elimination, terms used in pharmacokinetics and pharmacology to describe the drug disposition in human tissue. These set processes help in monitoring the performance of drugs in human tissue. It is widely used in biotechnology and pharmaceutical companies as it reduces the time and cost of drug discovery and development, toxicity testing. Prior to ADME, drug failure at later stages was higher; thus to avoid this hurdle in drug development, rapid adoption of ADME toxicity testing is observed in clinical trials. Furthermore, the rise in adoption of ADME toxicity testing which helps in reducing the cost and time drug development is the main driver of the market growth.
Market Segment Insights:
The global ADME toxicology testing market is majorly segmented by product type into instruments, software solutions, assays systems, reagent and others. Instruments and assay systems accounted for the largest market share in the global ADME toxicology testing market. On the basis of technology type, global ADME toxicology testing market is majorly segmented into in-vitro tests and in-vivo tests. In-vivo tests accounted the largest share in the market in terms of revenue due to its efficiency in terms of cost and time over other toxicity testing techniques.
Global ADME Toxicology Testing Market Segmentation:
By Product Type, 2018–2027 ($ Million)
- Software Solutions
- Assays Systems
By Technology Type, 2018–2027 ($ Million)
- In-vitro Tests
- Biochemical Testing
- Cell Testing
- In-vivo Tests
By Geography, 2018–2027 ($ Million
- North America (U.S. & Canada)
- Europe (U.K., Germany & Rest of Europe)
- Asia Pacific (China, Japan, and Rest of APAC)
- Latin America (Brazil, Mexico and Rest of LATAM)
- Middle East and Africa (UAE, Saudi Arabia, South Africa)
North America occupies the largest revenue share for the global ADME toxicology testing market, largely dominated by the U.S. Asia Pacific is expected to be the most attractive market and anticipates extensive growth during the forecast period. Major drivers for the growth are the rapid adoption of ADME toxicology testing, government initiative, and support in new drug development and toxicology testing.
Market Competition Assessment:
Key players in the ADME toxicology testing market are AMD Telemedicine, Philips Healthcare, GE Healthcare, Allscripts Healthcare Solutions, Honeywell Life Care Solutions, McKesson Corporation, Cisco Systems, Siemens Healthcare, Robert Bosch Healthcare and others.
List of Key Companies:
- Cellartis AB
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Caliper Life Sciences, Inc.
- Promega Corporation
- Beckman Coulter, Inc.
- Optivia Biotechnology, Inc.
- Cyprotex PLC
- Molecular Discovery Ltd.
Table of Content
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 ADME Toxicology Testing Market, by Product Type, 2019 ($ Million)
2.2 ADME Toxicology Testing Market Share, by Technology Type, 2019 (Value %)
2.3 ADME Toxicology Testing Market Share, by Geography, 2019 (Value %)
Chapter 3 Global ADME Toxicology Testing Market: Market Dynamics and Outlook
3.1 ADME Toxicology Testing: Current and Future Trends
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.6 Market Share Analysis: Key ADME Toxicology Testing Manufacturers, 2019 (Value %)
Chapter 4 Global ADME Toxicology Testing Market, by Product Type, 2018-2027 ($ Million)
4.3 Software Solutions
4.4 Assays systems
Chapter 5 Global ADME Toxicology Testing Market, by Technology Type, 2018-2027 ($ Million)
5.2 In-vitro Tests
5.2.1 Biochemical Testing
5.2.2 Cell Testing
5.3 In-vivo Tests
Chapter 6 Global ADME Toxicology Testing Market, by Geography, 2018-2027 ($ Million)
6.2 North America (U.S. & Canada)
6.3 Europe (U.K., Germany & Rest of Europe)
6.4 Asia Pacific (China, Japan, and Rest of APAC)
6.5 Latin Americas (Brazil, Mexico and Rest of LATAM)
6.6 Middle East and Africa (UAE, Saudi Arabia, South Africa)
Chapter 8 Company Profiles
8.1 Cellartis AB
8.2 Thermo Fisher Scientific, Inc.
8.3 Agilent Technologies, Inc.
8.4 Bio-Rad Laboratories, Inc.
8.5 Caliper Life Sciences, Inc.
8.6 Promega Corporation
8.7 Beckman Coulter, Inc.
8.8 Optivia Biotechnology, Inc.
8.9 Cyprotex PLC
8.10 Molecular Discovery Ltd.
$4800/- Multi User License $6400/- Corporate License
- Markets in over 150 countries analyzed granularly
- 35% of our total client are returning clients
- 100,000+ data points in our comprehensive database
- 24x5 availability - we are always there when you need us
- Our expert team will assist you with all research need and customization
- Our expert research analysts will resolve your every query before and after purchasing the report
- We focus on the accuracy and quality of the report
- Our analyst will provide deep insights into the report
Call Us: +1 520-686-7060